Viewing Study NCT05332834


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2025-12-26 @ 1:08 AM
Study NCT ID: NCT05332834
Status: COMPLETED
Last Update Posted: 2024-09-27
First Post: 2022-03-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase 1 Study of Single and Multiple Intravenous Doses of SM17 in Healthy Subjects
Sponsor: SinoMab BioScience Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module